IPP Bureau
Glenmark Pharma reports revenue growth of 5.6% YoY in Q4
By IPP Bureau - May 30, 2022
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
LintonPharm to release data on Catumaxomab at ASCO meeting
By IPP Bureau - May 30, 2022
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
Strides receives USFDA approval for Ibuprofen Oral Suspension
By IPP Bureau - May 30, 2022
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
Granules India chooses Veeam to protect digital business
By IPP Bureau - May 30, 2022
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
OS-SiA digital pathology scanner developed by OptraSCAN granted US patent
By IPP Bureau - May 30, 2022
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
Blockchain improves product authenticity in supply chain, finds GlobalData
By IPP Bureau - May 30, 2022
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors
North India’s first biotech park at Kathua, J&K inaugurated
By IPP Bureau - May 30, 2022
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
NHA launches online public dashboard for Ayushman Bharat Digital Mission (ABDM)
By IPP Bureau - May 30, 2022
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
Medisca inks distribution license with SUANFARMA
By IPP Bureau - May 29, 2022
Already an existing partner and supplier of ingredients to Medisca, striking this agreement with SUANFARMA involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price
Zydus receives EIR from USFDA for its injectables manufacturing facility at Jarod
By IPP Bureau - May 29, 2022
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
Venus Remedies registers 9.22 % growth in annual sales for FY22
By IPP Bureau - May 29, 2022
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
USFDA approves two Opdivo-based regimens
By IPP Bureau - May 29, 2022
Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers
USFDA approves Novartis Kymriah CAR-T cell therapy
By IPP Bureau - May 29, 2022
68% of patients receiving Kymriah in the ELARA trial experienced a complete response, with an 86% overall response rate, along with a remarkable safety profile
All India Institute of Ayurveda launches #YogaSeAyu campaign for International Day of Yoga 2022
By IPP Bureau - May 29, 2022
The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds
MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData
By IPP Bureau - May 29, 2022
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
